# The Neurobiology of Stress and the HPA Axis

## Introduction

The stress response is an evolutionarily conserved system that mobilizes physiological resources to meet perceived threats. At its core lies the **hypothalamic-pituitary-adrenal (HPA) axis**, a neuroendocrine cascade that regulates cortisol release. While adaptive in the short term, chronic dysregulation of the HPA axis has been implicated in depression, PTSD, anxiety disorders, psychosis, and a range of medical illnesses. Understanding this system is fundamental to psychiatric neuroscience.

## Anatomy of the Stress Response

### The Sympathetic-Adrenal-Medullary (SAM) System

The rapid "fight-or-flight" response mediated by the **sympathetic nervous system**. Preganglionic neurons activate the adrenal medulla to release **epinephrine and norepinephrine**. Effects: increased heart rate, blood pressure, bronchodilation, pupil dilation, glucose mobilization. Time course: seconds to minutes.

### The HPA Axis

The slower, sustained neuroendocrine stress response. **Hypothalamus** (paraventricular nucleus) releases corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) CRH acts on the **anterior pituitary** to stimulate release of adrenocorticotropic hormone (ACTH) ACTH stimulates the **adrenal cortex** to synthesize and release **cortisol** (glucocorticoid) Time course: minutes to hours.

### Negative Feedback

Cortisol binds to **glucocorticoid receptors (GR)** and **mineralocorticoid receptors (MR)** in the hypothalamus, pituitary, and hippocampus. This negative feedback loop terminates the stress response. MR (high affinity): active at basal cortisol levels, maintains homeostasis. GR (low affinity): activated during stress, mediates feedback inhibition.

![Schematic of the HPA axis with feedback loops and key regulatory structures](images/hpa-axis-schematic.png)

## Cortisol: Actions and Effects

### Adaptive Functions

Mobilizes glucose through hepatic gluconeogenesis. Enhances cardiovascular function and blood pressure. Modulates immune function (acute anti-inflammatory effects) Enhances consolidation of emotionally relevant memories (via amygdala)

### Maladaptive Effects of Chronic Elevation

**Hippocampal atrophy**: dendritic retraction, impaired neurogenesis, and volume loss. Impaired **prefrontal cortex** function: deficits in working memory, executive function, and cognitive flexibility. **Amygdala hypertrophy**: enhanced fear conditioning and hypervigilance. Immune suppression and chronic low-grade inflammation. Metabolic syndrome: visceral obesity, insulin resistance, dyslipidemia. Disrupted sleep architecture.

## HPA Axis Dysregulation in Psychiatric Disorders

| Disorder | HPA Pattern | Cortisol Level | Key Findings | Clinical Implication |
|----------|-------------|---------------|--------------|---------------------|
| Major Depression | Hyperactive | Elevated (subset) | Non-suppression on DST/DEX-CRH test; elevated CRH | Treatment normalizes; hippocampal volume loss correlates with duration |
| PTSD | Sensitized/enhanced feedback | Low basal cortisol | Increased GR sensitivity; enhanced suppression on low-dose DEX | Paradoxical hypo-cortisolism; early trauma programs axis |
| Anxiety Disorders | Hyperreactive | Elevated reactivity | Exaggerated cortisol response to psychosocial stressors | Stress vulnerability |
| First-Episode Psychosis | Hyperactive | Elevated | Precedes psychosis onset; correlates with symptom severity | May predict transition from prodrome |
| Early Life Adversity | Impaired feedback | Variable | Epigenetic GR gene methylation; reduced receptor expression | Lasting vulnerability to stress-related illness |

### Major Depressive Disorder

**Hypercortisolism** is a consistent finding in a subset of depressed patients. Elevated CRH levels in CSF. Non-suppression on the **dexamethasone suppression test (DST)** and combined DEX/CRH test. Hippocampal volume reduction correlates with duration of untreated depression. Effective antidepressant treatment normalizes HPA axis function.

### Post-Traumatic Stress Disorder

Paradoxically associated with **low cortisol levels** and enhanced negative feedback. Increased GR sensitivity. Elevated CRH with exaggerated cortisol suppression on low-dose dexamethasone testing. This profile may reflect a sensitized HPA axis from early trauma exposure.

### Early Life Adversity

Childhood abuse, neglect, and adverse experiences permanently alter HPA axis programming. **Epigenetic modifications**: methylation of the GR gene (NR3C1) promoter reduces receptor expression. Results in impaired cortisol feedback and chronic stress sensitivity. Mediates the association between early adversity and adult psychiatric illness.

### Other Disorders

**Anxiety disorders**: elevated cortisol reactivity to psychosocial stressors. **Psychosis**: HPA axis hyperactivity is present in first-episode psychosis and may precede onset. **Bipolar disorder**: cortisol dysregulation during mood episodes. **Cushing syndrome**: psychiatric symptoms (depression, psychosis, anxiety) in up to 70% of cases.

![HPA axis dysregulation patterns across major psychiatric disorders](images/hpa-axis-psychiatric-disorders.png)

## Stress, Neuroplasticity, and Resilience

### Allostatic Load

**Allostasis**: the process of maintaining stability through physiological change. **Allostatic load**: the cumulative wear and tear from chronic stress and repeated activation. High allostatic load predicts cardiovascular disease, cognitive decline, and psychiatric disorders.

### Protective Factors

Social support buffers cortisol reactivity. Exercise enhances neurogenesis and normalizes HPA axis function. **DHEA (dehydroepiandrosterone)**: an adrenal hormone with neuroprotective and anti-glucocorticoid effects. Neuropeptide Y (NPY): promotes resilience and reduces anxiety in stress-exposed individuals.

### Therapeutic Implications

Psychotherapy (particularly trauma-focused therapies) normalizes cortisol patterns. Mindfulness-based stress reduction lowers cortisol levels. Pharmacological targets under investigation: CRH receptor antagonists, GR modulators, FKBP5 inhibitors.

![Allostatic load model showing the progression from adaptive stress response to pathological overload](images/allostatic-load-model.png)

## Key Clinical Pearls

The HPA axis is not simply "on or off"; both hyper- and hypo-cortisolism are pathological depending on context. Hippocampal volume loss from chronic stress is partially reversible with antidepressant treatment and exercise. Early life adversity programs lasting HPA axis changes through epigenetic mechanisms; this connects ACEs research to neurobiology. Always consider medical mimics of HPA axis dysfunction: Cushing syndrome, Addison disease, exogenous corticosteroid use. The stress response illustrates why psychiatry must integrate biological, psychological, and social perspectives.

## References

1. McEwen BS. Allostasis and allostatic load: implications for neuropsychopharmacology. *Neuropsychopharmacology*. 2000;22(2):108-124.
2. Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. *Trends Neurosci*. 2008;31(9):464-468.
3. Yehuda R, Seckl J. Minireview: stress-related psychiatric disorders with low cortisol levels: a metabolic hypothesis. *Endocrinology*. 2011;152(12):4496-4503.
4. Weaver ICG, Cervoni N, Champagne FA, et al. Epigenetic programming by maternal behavior. *Nat Neurosci*. 2004;7(8):847-854.